Autophagy in major human diseases
Autophagy is a core molecular pathway for the preservation of cellular and organismal
homeostasis. Pharmacological and genetic interventions impairing autophagy responses …
homeostasis. Pharmacological and genetic interventions impairing autophagy responses …
Metabolism and mitochondria in polycystic kidney disease research and therapy
V Padovano, C Podrini, A Boletta… - Nature Reviews …, 2018 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common,
potentially lethal, monogenic diseases and is caused predominantly by mutations in …
potentially lethal, monogenic diseases and is caused predominantly by mutations in …
Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases
Nutrients such as glucose, amino acids and lipids are fundamental sources for the
maintenance of essential cellular processes and homeostasis in all organisms. The nutrient …
maintenance of essential cellular processes and homeostasis in all organisms. The nutrient …
Emerging role of autophagy in kidney function, diseases and aging
Autophagy is a highly conserved process that degrades cellular long-lived proteins and
organelles. Accumulating evidence indicates that autophagy plays a critical role in kidney …
organelles. Accumulating evidence indicates that autophagy plays a critical role in kidney …
[HTML][HTML] Autophagy in kidney disease and aging: lessons from rodent models
O Lenoir, PL Tharaux, TB Huber - Kidney international, 2016 - Elsevier
Autophagy is a highly regulated lysosomal protein degradation pathway that removes
protein aggregates and damaged or excess organelles to maintain intracellular homeostasis …
protein aggregates and damaged or excess organelles to maintain intracellular homeostasis …
Autophagy in kidney disease
ME Choi - Annual review of physiology, 2020 - annualreviews.org
Autophagy is a cellular homeostatic program for the turnover of cellular organelles and
proteins, in which double-membraned vesicles (autophagosomes) sequester cytoplasmic …
proteins, in which double-membraned vesicles (autophagosomes) sequester cytoplasmic …
Indoxyl sulfate contributes to mTORC1-induced renal fibrosis via the OAT/NADPH oxidase/ROS pathway
T Nakano, H Watanabe, T Imafuku, K Tokumaru, I Fujita… - Toxins, 2021 - mdpi.com
Activation of mTORC1 (mechanistic target of rapamycin complex 1) in renal tissue has been
reported in chronic kidney disease (CKD)-induced renal fibrosis. However, the molecular …
reported in chronic kidney disease (CKD)-induced renal fibrosis. However, the molecular …
Apoptosis and autophagy in polycystic kidney disease (PKD)
KL Nowak, CL Edelstein - Cellular signalling, 2020 - Elsevier
Apoptosis in the cystic epithelium is observed in most rodent models of polycystic kidney
disease (PKD) and in human autosomal dominant PKD (ADPKD). Apoptosis inhibition …
disease (PKD) and in human autosomal dominant PKD (ADPKD). Apoptosis inhibition …
Diagnosis and management of childhood polycystic kidney disease
WE Sweeney, ED Avner - Pediatric nephrology, 2011 - Springer
A number of syndromic disorders have renal cysts as a component of their phenotypes.
These disorders can generally be distinguished from autosomal dominant polycystic kidney …
These disorders can generally be distinguished from autosomal dominant polycystic kidney …
Folate-conjugated rapamycin slows progression of polycystic kidney disease
JM Shillingford, CP Leamon, IR Vlahov… - Journal of the …, 2012 - journals.lww.com
Activation of the mammalian target of rapamycin (mTOR) signaling pathway is aberrant in
autosomal-dominant polycystic kidney disease (ADPKD). The mTOR inhibitors, such as …
autosomal-dominant polycystic kidney disease (ADPKD). The mTOR inhibitors, such as …